BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 51 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,658 | -1.5% | 50,882,000 | 0.0% | 0.07% | +9.5% |
| Q2 2023 | $51,406 | -4.2% | 50,882,000 | -0.6% | 0.06% | -10.0% |
| Q1 2023 | $53,645 | -94.7% | 51,188,000 | – | 0.07% | +6900.0% |
| Q1 2022 | $1,006,000 | -85.5% | 0 | -100.0% | 0.00% | -85.7% |
| Q4 2021 | $6,961,000 | -49.1% | 6,642,000 | -51.1% | 0.01% | -53.3% |
| Q3 2021 | $13,674,000 | -4.3% | 13,595,000 | -4.2% | 0.02% | -6.2% |
| Q2 2021 | $14,293,000 | – | 14,195,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 55,306,226 | $54,866,518 | 2.72% |
| MACKAY SHIELDS LLC | 76,286,000 | $74,883,901 | 2.06% |
| Sonora Investment Management Group, LLC | 10,890,000 | $10,840,075 | 0.93% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 39,812,000 | $39,636,827 | 0.92% |
| BANQUE PICTET & CIE SA | 636,000 | $63,228,545 | 0.75% |
| PIER 88 INVESTMENT PARTNERS LLC | 1,902,000 | $1,884,616 | 0.47% |
| LOOMIS SAYLES & CO L P | 2,074,551 | $183,557 | 0.32% |
| Liberty Mutual Group Asset Management Inc. | 1,025,000 | $1,015 | 0.28% |
| iA Global Asset Management Inc. | 14,690,000 | $14,625 | 0.24% |
| RATIONAL ADVISORS LLC | 1,803,000 | $1,786,052 | 0.16% |